Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis
Jiqing Cao, Margaret B. Zhong, Carlos A. Toro, et al.
Neuroscience Letters (2019) Vol. 703, pp. 68-78
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 103-197
Closed Access | Times Cited: 75
mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder
Marzia Perluigi, Fabio Di Domenico, Eugenio Barone, et al.
Free Radical Biology and Medicine (2021) Vol. 169, pp. 382-396
Open Access | Times Cited: 92
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
Grazia R. Tundo, Diego Sbardella, Anna Maria Santoro, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107579-107579
Open Access | Times Cited: 86
The Roles of the Ubiquitin–Proteasome System in the Endoplasmic Reticulum Stress Pathway
Junyan Qu, Tingting Zou, Zhenghong Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1526-1526
Open Access | Times Cited: 76
Glucose metabolism and AD: evidence for a potential diabetes type 3
Andrea González, Camila Calfío, Macarena Churruca, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 61
The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives
Maria Carolina Jurcău, Felicia Liana Andronie-Cioară, Anamaria Jurcău, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2167-2167
Open Access | Times Cited: 55
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Simone Lista, Raúl González‐Domínguez, Susana López‐Ortiz, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101987-101987
Closed Access | Times Cited: 33
Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
Jinhai Wang, Ying Fang, Rong Fan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11595-11595
Open Access | Times Cited: 42
TRIM25 inhibits infectious bursal disease virus replication by targeting VP3 for ubiquitination and degradation
Suyan Wang, Mengmeng Yu, Aijing Liu, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009900-e1009900
Open Access | Times Cited: 41
Preserved autophagy in cognitively intact non‐demented individuals with Alzheimer's neuropathology
Batbayar Tumurbaatar, Anna Fracassi, Pietro Scaduto, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5355-5370
Open Access | Times Cited: 17
Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model
Jamal B. Williams, Qing Cao, Wei Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy
Kundlik Gadhave, Deepak Kumar, Vladimir N. Uversky, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 5, pp. 2689-2745
Open Access | Times Cited: 47
The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer’s Disease
Sanjib Guha, Gail V.W. Johnson, Keith Nehrke
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5103-5120
Open Access | Times Cited: 39
Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes
Gabriela Dumitrița Stanciu, Răzvan Nicolae Rusu, Veronica Bild, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 576-576
Open Access | Times Cited: 36
Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review
David Vicente-Zurdo, Noelia Rosales‐Conrado, María Eugenia León‐González
Talanta (2023) Vol. 269, pp. 125519-125519
Open Access | Times Cited: 13
Fully Human Bifunctional Intrabodies Achieve Graded Reduction of Intracellular Tau and Rescue Survival of MAPT Mutation iPSC-derived Neurons
Lianna D’Brant, Natasha Rugenstein, Su Kyoung Na, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions
Sean S. Davies, Linda Zhang, Olivier Boutaud, et al.
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107418-107418
Open Access | Times Cited: 40
Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases
Saeideh Momtaz, Zahra Memariani, Fardous F. El‐Senduny, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 34
All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration
Shirel Argueti-Ostrovsky, Leenor Alfahel, Joy Kahn, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2438-2438
Open Access | Times Cited: 32
Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties
Vinayak Nayak, Sushmita Patra, Shrushti Rout, et al.
Phytomedicine (2023) Vol. 122, pp. 155150-155150
Closed Access | Times Cited: 11
Degradation of misfolded proteins by ubiquitin-proteasome system and autophagy lysosomal proteolytic pathways
Prasann Kumar, Amit Raj
Elsevier eBooks (2025), pp. 253-289
Closed Access
Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration
Jingyu Mu, Zengrui Zhang, Chao Jiang, et al.
Journal of Ophthalmology (2025) Vol. 2025, Iss. 1
Open Access
Mechanism of Tau Protein Incorporation into Exosomes via Cooperative Recognition of KFERQ-like Motifs by LAMP2A and HSP70
Shan Xu, Kan Liu, Shiyan Qian, et al.
Neurochemistry International (2025), pp. 105976-105976
Closed Access
Truncated tau interferes with the autophagy and endolysosomal pathway and results in lipid accumulation
Saskia J. Pollack, Dina Dakkak, Tong Guo, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Anatomical, Physiological, and Pathological Changes in Different Parts of the Brain in Alzheimer's Disease
Sadegh Shirian, Narges Tahmasebian, Behnam Bakhtiari Moghadm, et al.
The Neuroscience Journal of Shefaye Khatam (2024) Vol. 12, Iss. 3, pp. 103-116
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top